ORPHARMA LIMITED

Company Registration Number:
09335342 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

ORPHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Notes

ORPHARMA LIMITED

Balance sheet

As at 31 December 2022


Notes

2022

2021


£

£
Called up share capital not paid: 3 3
Current assets
Debtors:   289,926 287,926
Total current assets: 289,926 287,926
Creditors: amounts falling due within one year:   (473) (93)
Net current assets (liabilities): 289,453 287,833
Total assets less current liabilities: 289,456 287,836
Total net assets (liabilities): 289,456 287,836
Capital and reserves
Called up share capital: 3 3
Other reserves: 287,833 287,439
Profit and loss account: 1,620 394
Shareholders funds: 289,456 287,836

The notes form part of these financial statements

ORPHARMA LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 01 December 2023
and signed on behalf of the board by:

Name: Paul Newman
Status: Director

The notes form part of these financial statements

ORPHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ORPHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

2. Employees

2022 2021
Average number of employees during the period 0 0